Drugs and Medical Devices BACK TO CAPABILITIES News & Insights / Drugs and Medical Devices News 04.23.25 HLB Lawyers Published in Law360, “What’s Next For Lab Test Regulation Without FDA Authority” Insights 04.03.25 Texas Federal District Court Vacates Final Rule Regulating Laboratory Developed Tests Insights 01.04.24 FTC and DOJ Jointly Release Final Merger Guidelines Events 12.11.23 HLB Webinar: A Brave New World – California’s New Pre-Transaction Notice and Cost and Market Impact Review Insights 11.15.23 HHS-OIG Releases New Compliance Guidance for Healthcare Providers News 07.06.23 Amy Joseph, Jeremy Sherer, and Stephen Phillips Published in Westlaw Today, “The rise of artificial intelligence: navigating health care regulatory considerations” Insights 06.07.23 The Rise of Artificial Intelligence: Navigating Healthcare Regulatory Considerations Events 07.09.19 The First Half is In the Books — What’s In Store for the Rest of 2019 Insights 11.15.23 HHS-OIG Releases New Compliance Guidance for Healthcare Providers News 07.06.23 Amy Joseph, Jeremy Sherer, and Stephen Phillips Published in Westlaw Today, “The rise of artificial intelligence: navigating health care regulatory considerations” Events 12.11.23 HLB Webinar: A Brave New World – California’s New Pre-Transaction Notice and Cost and Market Impact Review Insights 01.04.24 FTC and DOJ Jointly Release Final Merger Guidelines News 04.23.25 HLB Lawyers Published in Law360, “What’s Next For Lab Test Regulation Without FDA Authority” Insights 04.03.25 Texas Federal District Court Vacates Final Rule Regulating Laboratory Developed Tests Previous Next
